Desk›Chemicals› Eiko Lifesciences Ltd
Eiko Lifesciences Ltd
BSE 540204 · NSE EIKO · ISIN INE666Q01016 · Group X · Active
Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals
₹47.99
+2.02%
BSE close, 28 August 2026
₹68.85 cr
1.4 cr shares · Micro cap
₹42.76 cr
as published
17.4× · 1.34×
EPS ₹2.76 · BV ₹35.81
42.13 / 3.58
₹ cr, as filed
15
3 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -25.5% |
|---|---|
| Against 52-week low | +7.2% |
| Day change | +2.02% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹2.76 |
|---|---|
| Price / earnings | 17.39× |
| Price / book | 1.34× |
| Book value — derived, price ÷ P/B | ₹35.81 |
| Return on equity | 7.72% |
| Operating margin | 11.23% |
| Net margin | 7.50% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 7.71%
- ROE as published
- 7.72%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 14.18 | 1.06 | 0.74 | 11.23% | 7.50% |
| Mar-26 · Q | 15.90 | 1.12 | 0.80 | 10.55% | 7.07% |
| FY25-26 | 42.13 | 3.58 | 2.60 | 12.98% | 8.50% |
Quarter on quarter
- Revenue, quarter on quarter
- -10.8%
- Net profit, quarter on quarter
- -5.4%
- Operating margin, quarter on quarter
- +68 bps
Disclosure profile 15 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Resignation | 1 |
| Selected sub-total | 3 |
| Procedural | |
| AGM / EGM | 3 |
| General | 2 |
| Newspaper Publication | 2 |
| Allotment | 1 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Outcome | 1 |
| Trading Window | 1 |
| Procedural sub-total | 12 |
| Total | 15 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
15 filings · 3 selected · busiest 2026-08-24
Filing rhythm · the twelve most recent
2026-08-182026-09-24
SelectedProcedural
Filings
15 in the window · 2 earlier on record
-
24 September 2026 ·
Closure of Trading Window
Pursuant to SEBI (PIT) Regulations, 2015 as amended and as per Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window for dealing ....
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
With refrence to the 49th Annual General Meeting of the Company held on Tuesday, 22nd September, 2026 at 04:00 P.M. IST through Video Conference/ Other Audio Visual Means, please find attached ....
AGM/EGM / AGM View filing →
-
22 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
The Proceedings of the 49th Annual General Meeting (AGM) of Eiko LifeSciences Limited held on Tuesday, 22nd September, 2026 at 04:00 P.M. IST through Video Conferencing ('VC')/ Other Audio-Visual ....
AGM/EGM / AGM View filing →
-
27 August 2026 ·
Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 ('The Listing Regulations')
The Company has sent a letter providing the weblink and QR Code for accessing the Notice convening the 49th Annual General Meeting ("AGM") and the Annual Report of the Company for the Financial ....
Company Update / General View filing →
-
25 August 2026 ·
Newspaper Publication
Newspaper Advertisement for 49th Annual General Meeting (AGM) of the Company scheduled to be held on Tuesday, 22nd day of September, 2026 at 04:00 P.M. IST through Video Conference / Other ....
Company Update / Newspaper Publication View filing →
-
24 August 2026 ·
Reg. 34 (1) Annual Report.
Pursuant to provision of Regulations 30 and 34 of the SEBI LODR Regulations, 2015, we wish to inform that the 49th Annual General Meeting of the Company will be held on Tuesday, 22nd day ....
Others / Reg. 34 (1) Annual Report View filing →
-
24 August 2026 ·
49Th Annual General Meeting Of The Company Will Be Held On Tuesday, 22Nd Day Of September, 2026 At 04:00 P.M. (IST) Through Video Conferencing/ Other Audio Visual Means.
Pursuant to provision of Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the 49th Annual General Meeting of ....
AGM/EGM / AGM View filing →
-
24 August 2026 ·
Resignation of Director
The Meeting of the Board of Directors of the Company held today i.e., on Monday, 24th August, 2026, Board, inter-alia, considered the following: 1. Noting of resignation of Ms. Hasti ....
Company Update / Resignation of Director View filing →
-
24 August 2026 ·
Change in Management
Appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director (Independent and Non-Executive) of the Company to hold the office up to the date of the ensuing Annual General ....
Company Update / Change in Management View filing →
-
24 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, 24Th August, 2026
Meeting of the Board of Directors of the Company held today i.e., on Monday, 24th August, 2026, Board, inter-alia, considered the following: 1. Noting of resignation of Ms. Hasti Doshi ....
Others / Outcome without intimation View filing →
-
18 August 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
As per PDF attached.
Company Update / General View filing →
-
18 August 2026 ·
Allotment
Disclosure of Conversion of 305000 Warrants into Equity Shares belonging to Promoter and Non Promoter Category
Company Update / Allotment of Equity Shares View filing →
-
13 August 2026 ·
Newspaper Publication
Pursuant to Regulations 30 and 47 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, The copy of newspaper publication in the following ....
Company Update / Newspaper Publication View filing →
-
12 August 2026 ·
Board Meeting Outcome for Approved Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2026 Along With Limited Review Report Issued By The Statutory Auditors Of The Company.
Pursuant to the Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments ....
Board Meeting / Outcome of Board Meeting View filing →
-
7 August 2026 ·
Board Meeting Intimation for Meeting Scheduled To Be Held On 12Th August, 2026
Eiko Lifesciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve The Unaudited Standalone ....
Board Meeting / Board Meeting View filing →
RSS feed for Eiko Lifesciences Ltd · the 50 most recent filings